News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
145,833 Results
Type
Article (14266)
Company Profile (9)
Press Release (131558)
Section
Business (39464)
Career Advice (207)
Deals (5340)
Drug Delivery (16)
Drug Development (18514)
Employer Resources (25)
FDA (2842)
Job Trends (3174)
News (65499)
Policy (5306)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (1)
2024 Biotech Bay Standard (1)
Academia (1698)
Adcomms (11)
Allergies (13)
Alliances (12541)
ALS (19)
Alzheimer's disease (477)
Antibody-drug conjugate (ADC) (18)
Approvals (2855)
Artificial intelligence (63)
Autoimmune disease (1)
Automation (2)
Bankruptcy (31)
Best Places to Work (2719)
BIOSECURE Act (14)
Biosimilars (7)
Biotechnology (6)
Bladder cancer (19)
Brain cancer (9)
Breast cancer (71)
Cancer (574)
Cardiovascular disease (30)
Career advice (193)
Career pathing (4)
CAR-T (39)
Cell therapy (96)
Cervical cancer (10)
Clinical research (14254)
Collaboration (196)
Compensation (10)
Complete response letters (2)
COVID-19 (1028)
CRISPR (11)
C-suite (54)
Cystic fibrosis (22)
Data (447)
Depression (3)
Diabetes (32)
Diagnostics (1628)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (24)
Drug pricing (19)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (8980)
Editorial (5)
Employer branding (3)
Employer resources (20)
Events (18650)
Executive appointments (130)
FDA (3064)
Featured Employer (2)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (258)
Gene editing (20)
Generative AI (2)
Gene therapy (82)
GLP-1 (103)
Government (1139)
Guidances (10)
Healthcare (4829)
Huntington's disease (1)
Immunology and inflammation (11)
Indications (3)
Infectious disease (1059)
Inflammatory bowel disease (31)
Inflation Reduction Act (2)
Influenza (6)
Intellectual property (11)
Interviews (19)
IPO (2728)
IRA (12)
Job creations (545)
Job search strategy (184)
Kidney cancer (5)
Labor market (7)
Layoffs (44)
Legal (922)
Liver cancer (20)
Lung cancer (94)
Lymphoma (37)
Machine learning (2)
Management (6)
Manufacturing (48)
MASH (9)
Medical device (2409)
Medtech (2409)
Mergers & acquisitions (2733)
Metabolic disorders (59)
Multiple sclerosis (15)
NASH (4)
Neurodegenerative disease (10)
Neuropsychiatric disorders (2)
Neuroscience (575)
NextGen: Class of 2025 (1609)
Non-profit (1867)
Northern California (415)
Now hiring (5)
Obesity (20)
Opinion (46)
Ovarian cancer (26)
Pain (19)
Pancreatic cancer (15)
Parkinson's disease (26)
Partnered (5)
Patents (24)
Patient recruitment (23)
Peanut (9)
People (15092)
Pharmaceutical (5)
Phase I (4833)
Phase II (6555)
Phase III (4319)
Pipeline (196)
Policy (41)
Postmarket research (547)
Preclinical (2203)
Press Release (18)
Prostate cancer (23)
Psychedelics (10)
Radiopharmaceuticals (47)
Rare diseases (71)
Real estate (1191)
Recruiting (11)
Regulatory (3622)
Reports (9)
Research institute (1864)
Resumes & cover letters (16)
RNA editing (1)
RSV (5)
Schizophrenia (11)
Series A (41)
Series B (16)
Sickle cell disease (19)
Southern California (379)
Spinal muscular atrophy (23)
Sponsored (1)
Startups (1062)
Stomach cancer (3)
Supply chain (11)
United States (4180)
Vaccines (202)
Venture capitalists (11)
Webinars (3)
Weight loss (9)
Women's health (3)
Worklife (3)
Date
Today (57)
Last 7 days (161)
Last 30 days (566)
Last 365 days (6860)
2025 (1562)
2024 (7215)
2023 (8724)
2022 (11563)
2021 (12896)
2020 (12195)
2019 (10947)
2018 (8106)
2017 (7360)
2016 (7419)
2015 (8727)
2014 (6474)
2013 (5336)
2012 (5415)
2011 (5641)
2010 (4820)
Location
Africa (189)
Alabama (29)
Alaska (3)
Arizona (46)
Arkansas (3)
Asia (9168)
Australia (2042)
California (970)
Canada (325)
China (64)
Colorado (46)
Connecticut (44)
Delaware (33)
Europe (19134)
Florida (199)
Georgia (19)
Idaho (11)
Illinois (111)
India (5)
Indiana (43)
Japan (35)
Kansas (20)
Kentucky (11)
Louisiana (1)
Maine (9)
Maryland (148)
Massachusetts (717)
Michigan (27)
Minnesota (64)
Missouri (24)
Montana (6)
Nebraska (4)
Nevada (4)
New Hampshire (12)
New Jersey (445)
New Mexico (6)
New York (345)
North Carolina (153)
North Dakota (3)
Northern California (415)
Ohio (45)
Oklahoma (5)
Oregon (8)
Pennsylvania (225)
Rhode Island (6)
South America (259)
South Carolina (5)
Southern California (379)
Tennessee (19)
Texas (217)
Utah (29)
Virginia (26)
Washington D.C. (31)
Washington State (122)
West Virginia (1)
Wisconsin (8)
145,833 Results for "institut gustave roussy".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sofinnova Partners and Gustave Roussy launch first biotech company through Strategic Partnership
March 18, 2025
·
4 min read
BioMidwest
Spectrum Dynamics is proud to announce the Installation of the VERITON-CT SPECT/CT imaging system at European Leading Cancer Center, Gustave Roussy
Spectrum Dynamics Medical, a leading innovator in diagnostic imaging solutions, announced that its VERITON-CT 400, a new generation of digital SPECT/CT was successfully installed and patient scanning was started at Gustave Roussy, Grand Paris, France.
March 20, 2024
·
3 min read
Business
Sofinnova Partners and Gustave Roussy forge strategic alliance to boost oncology startup acceleration in France
Sofinnova Partners and Gustave Roussy announced the launch of a strategic collaboration as part of Sofinnova Biovelocita, the first pan-European investment strategy dedicated to the creation and acceleration of biotech startups.
December 13, 2023
·
5 min read
Business
SOPHiA GENETICS Expands Relationship with Gustave Roussy
SOPHiA GENETICS, a cloud-native software company in the healthcare space and a leader in data-driven medicine, announced the expansion of its relationship with Gustave Roussy, the leading cancer center in Europe.
August 22, 2023
·
5 min read
Business
Veracyte and Gustave Roussy Announce Collaboration to Help Biopharmaceutical Companies Accelerate Development of Novel Cancer Therapies
Partnership will leverage Gustave Roussy’s tumor samples and Veracyte’s Biopharma Atlas multi-omic database and machine learning capabilities.
September 6, 2023
·
6 min read
Gustave Roussy and THERYQ: France welcomes the first FLASH radiotherapy machine to treat patients
Gustave Roussy and THERYQ announce a strategic and structuring partnership to roll out and assess FLASH technology for radiotherapy.
July 12, 2023
·
3 min read
Pharm Country
The Gustave Roussy Institute Integrates Synapse Platform to Ensure Complex Prescription Safety
France’s Gustave Roussy Institute, Europe’s leading cancer center and ranked third in the world according to Newsweek Magazine, has chosen to partner with Synapse Medicine, a leader in clinical pharmacy and medication reconciliation.
December 1, 2022
·
4 min read
Business
LinKinVax and Gustave Roussy Announced First Patient Dosed in Phase I/IIa Clinical Study on HPV.DCVax in HPV-positive Oropharyngeal Cancer
LinKinVax, a clinical-stage biotechnology company focusing on innovative protein-based vaccines, and Gustave Roussy, the leading cancer centre in Europe ranked third Best Cancer Hospital in the world, announced the treatment at Gustave Roussy of the first patient in a Phase I/IIa clinical study with CD40HVac, a new therapeutic vaccine candidate for HPV-positive oropharyngeal cancer.
September 18, 2023
·
3 min read
Business
LinKinVax and Gustave Roussy Collaborate on a Phase I/IIa HPV.DCVax Clinical Trial for the Treatment of Patients with HPV-Positive Oropharyngeal Cancer
LinKinVax and Gustave Roussy announced a collaboration to conduct a first-in-human Phase I/IIa clinical trial with CD40HVac, a new therapeutic vaccine candidate against head and neck cancer associated with human papillomavirus (HPV).
January 19, 2023
·
4 min read
OSE Immunotherapeutics KOL Investor Webinar on the Therapeutic Landscape and Unmet Medical Needs in Non-Small Cell Lung Cancer by Dr Stephen Liu and Prof Benjamin Besse
OSE Immunotherapeutics joins key opinion leaders Dr Stephen Liu, associate professor and director of Thoracic Oncology at Georgetown University Lombardi Comprehensive Cancer Center and Prof Benjamin Besse, medical oncologist and director of clinical research at the Gustave Roussy Institute, to discuss the current unmet medical needs in lung cancer therapeutics and the development landscape of OSE Immunotherapeutics therapeutic cancer vaccine, Tedopi®.
June 12, 2024
·
5 min read
1 of 14,584
Next